One Platform. Many Applications.
BioThera produces and characterizes extracellular vesicles at manufacturing scale. What those vesicles become is an application question, not a platform one. Cosmetic applications reach the market today through an exclusive licensing partner, and our research team is working on what comes next, including therapeutic applications.
Characterized material, documented batch by batch.
Material
Characterized EV bulk
Extracellular vesicles isolated at manufacturing scale, counted by Nanoparticle Tracking Analysis and characterized in line with the MISEV2023 framework. Our current material is plant-derived.
Documentation
Batch-specific CoA
Every batch ships with its own Certificate of Analysis: particle concentration, EV marker panel, and contamination screen. MISEV2023 disclosures available on request.
Stability
Cold chain and lyophilization
Material is kept frozen under cold-chain protocols from production onward, or lyophilized (freeze-dried) where a frozen supply chain is impractical. Stability is handled by our scientific team.
One platform, several fields of use.
Cosmetic use is the only commercial application of our material today. Everything else on this page is research: an important focus for our team, but not a product, and not offered for sale.
Cosmetics & skincare
Our technology is licensed exclusively to Vesera™, a skincare company, for cosmetic use, and we produce the EV material it uses.
Dermatology
Research with practicing dermatologists into how characterized extracellular vesicles behave in skin.
Tissue repair & regenerative medicine
Research into the vesicle cargo associated with tissue repair and regeneration.
Drug delivery
Research into extracellular vesicles as a natural carrier for therapeutic payloads.
Licensed exclusively to Vesera™.
For cosmetic applications, BioThera licenses its technology exclusively to Vesera™, a skincare company formulating for professional skin care, and produces the plant-derived extracellular vesicles Vesera™ uses, characterized in line with MISEV2023 on every batch. Vesera™ products have completed Health Canada's cosmetic notification and can be legally distributed and sold in Canada. Vesera™ is responsible for its own products, claims and sales.
- Exclusive licence of BioThera technology for cosmetic applications
- EV material produced and characterized by BioThera
- Characterized in line with MISEV2023 on every batch
- Health Canada cosmetic notification completed
Standards we manufacture to
Health Canada: Cosmetic Regulations (C.R.C., c. 869)
Health Canada cosmetic notification completed for products made with our material, which can be legally distributed and sold in Canada under the Cosmetic Regulations (C.R.C., c. 869), made under the Food and Drugs Act.
MISEV2023 Characterization
Characterized in line with the Minimal Information for Studies of Extracellular Vesicles (MISEV2023), the consensus framework published by the International Society for Extracellular Vesicles (ISEV).
Leaping Bunny Cruelty-Free Certification
Active certification. No animal testing at any stage of production or supply chain.
GMP/ISO-Aligned Manufacturing
Manufacturing process under active development toward GMP and ISO alignment as we scale the platform.
Products sold under the Vesera™ brand are cosmetics under Canada's Cosmetic Regulations and are not intended to diagnose, treat, cure, or prevent any disease. BioThera's work on other applications, including therapeutic ones, is research only: it is not a product, is not offered for sale, and carries no therapeutic claim.
Talk to us about partnering or co-development.
Whether you want to explore co-development, licensing or a research collaboration, start with a conversation.
Contact the team